2011
DOI: 10.1158/1940-6207.capr-10-0331
|View full text |Cite
|
Sign up to set email alerts
|

Preventive Effects of (−)-Epigallocatechin Gallate on Diethylnitrosamine-Induced Liver Tumorigenesis in Obese and Diabetic C57BL/KsJ-db/db Mice

Abstract: Obesity and related metabolic abnormalities, including insulin resistance and a state of chronic inflammation, increase the risk of hepatocellular carcinoma. Abnormal activation of the insulin-like growth factor (IGF)/ IGF-1 receptor (IGF-1R) axis is also involved in obesity-related liver tumorigenesis. In the present study, we examined the effects of (À)-epigallocatechin gallate (EGCG), a major biologically active component of green tea, on the development of diethylnitrosamine (DEN)-induced liver tumorigenes… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

7
66
0

Year Published

2011
2011
2017
2017

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 77 publications
(73 citation statements)
references
References 50 publications
7
66
0
Order By: Relevance
“…significantly associated with the development of liver tumors in obese mice, and that inhibiting the activation of these signaling pathways is critical to the prevention of obesity-related liver tumorigenesis (34,35). These reports (34,35), together with the present findings that specific inhibitors of PI3K, MEK1, and GSK-3b significantly suppress visfatin-induced proliferation in HCC cells, suggest that visfatin and its related signaling pathways might be effective targets for inhibiting obesity-related liver carcinogenesis.…”
Section: Discussionsupporting
confidence: 62%
See 2 more Smart Citations
“…significantly associated with the development of liver tumors in obese mice, and that inhibiting the activation of these signaling pathways is critical to the prevention of obesity-related liver tumorigenesis (34,35). These reports (34,35), together with the present findings that specific inhibitors of PI3K, MEK1, and GSK-3b significantly suppress visfatin-induced proliferation in HCC cells, suggest that visfatin and its related signaling pathways might be effective targets for inhibiting obesity-related liver carcinogenesis.…”
Section: Discussionsupporting
confidence: 62%
“…These reports (34,35), together with the present findings that specific inhibitors of PI3K, MEK1, and GSK-3b significantly suppress visfatin-induced proliferation in HCC cells, suggest that visfatin and its related signaling pathways might be effective targets for inhibiting obesity-related liver carcinogenesis.…”
Section: Discussionsupporting
confidence: 61%
See 1 more Smart Citation
“…In addition, HCC development is frequently associated with chronic inflammation and subsequent liver cirrhosis induced by a persistent infection with hepatitis viruses. Recent evidence also indicates that obesity and related metabolic abnormalities, especially insulin resistance, increase the risk for live cancer [105,106], while GTCs appear to exert anti-obesity and anti-diabetic activity [107,108]. Therefore, well-designed interventional clinical trials should be conducted to investigate whether GTCs are able to prevent the development of HCC in high-risk patients with viral liver cirrhosis and obesity.…”
Section: Clinical Interventional Studiesmentioning
confidence: 99%
“…In previous studies, various pathophysiological mechanisms linking obesity to cancer have been suggested. Insulin resistance and subsequent abnormal activation of insulin-like growth factor (IGF) and the IGF-1 axis has been considered to play a key role in carcinogenesis (van Kruijsdijk et al, 2009;Shimizu et al, 2011). Other possible mechanisms include dysfunction of adipose tissue due to dysregulation of adipocytokines such as adiponectin, leptin, and plasminogen activator inhibitor-1 resulting from the enlargement of adipocytes (Shimizu et al, 2011).…”
Section: Introductionmentioning
confidence: 99%